carbachol has been researched along with Gastroenteritis in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Gastroenteritis: INFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER.
Excerpt | Relevance | Reference |
---|---|---|
"To investigate the effects of carbachol on local inflammation in gut tissue during ischemia/reperfusion (I/R)." | 7.72 | [Carbachol alleviates inflammation in gut tissue during ischemia/reperfusion in rats]. ( Hu, S; Jiang, XG; Li, JY; Lu, Y; Sheng, ZY; Shi, DG; Sun, D, 2003) |
"To investigate the effects of carbachol on local inflammation in gut tissue during ischemia/reperfusion (I/R)." | 3.72 | [Carbachol alleviates inflammation in gut tissue during ischemia/reperfusion in rats]. ( Hu, S; Jiang, XG; Li, JY; Lu, Y; Sheng, ZY; Shi, DG; Sun, D, 2003) |
"Acute gastroenteritis is a strong risk factor for the development of irritable bowel syndrome (IBS)." | 1.33 | Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. ( Akiho, H; Blennerhassett, P; Collins, SM; Deng, Y; Kanbayashi, H, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, S | 1 |
Jiang, XG | 1 |
Shi, DG | 1 |
Lu, Y | 1 |
Li, JY | 1 |
Sun, D | 1 |
Sheng, ZY | 1 |
Akiho, H | 1 |
Deng, Y | 1 |
Blennerhassett, P | 1 |
Kanbayashi, H | 1 |
Collins, SM | 1 |
2 other studies available for carbachol and Gastroenteritis
Article | Year |
---|---|
[Carbachol alleviates inflammation in gut tissue during ischemia/reperfusion in rats].
Topics: Animals; Carbachol; Gastroenteritis; Intestines; Ischemia; Peroxidase; Rats; Rats, Wistar; Reperfusi | 2003 |
Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction.
Topics: Acute Disease; Animals; Carbachol; Cells, Cultured; Cholinergic Agonists; Chronic Disease; Cyclooxyg | 2005 |